ArticleOphthalmology science2022

Topical Nanoemulsion of a Runt-related Transcription Factor 1 Inhibitor for the Treatment of Pathologic Ocular Angiogenesis.

Santiago Delgado-Tirado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.